Fundraising FoxKalohexis
1 known investors
Find your way into Kalohexis
Sign up to see every warm intro you have to Kalohexis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kalohexis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kalohexis is a biopharmaceutical company developing treatments that target the melanocortin system, the body's regulator of metabolic homeostasis, to address metabolic disorders beginning with obesity and cancer cachexia. Its therapies aim to adjust the body's metabolic set-point for patients with metabolic disease.
Investors · 1
Frequently asked questions
- What does Kalohexis do?
- Kalohexis is a biopharmaceutical company developing treatments that target the melanocortin system, the body's regulator of metabolic homeostasis, to address metabolic disorders beginning with obesity and cancer cachexia. Its therapies aim to adjust the body's metabolic set-point for patients with metabolic disease.
- Who are Kalohexis's investors?
- Kalohexis's investors include Centennial Investors.